Karolien Jaspers1,2, Tim Leiner1,2,
1Cardiovascular Research Insitute
Maastricht, Maastricht, Netherlands; 2Radiology, Maastricht
University Medical Centre, Maastricht, Netherlands; 3Central
Animal Facilities, Maastricht University, Maastricht, Netherlands; 4Internal
Medicine, Maastricht University Medical Centre, Maastricht, Netherlands; 5Physiology,
Maastricht University, Maastricht, Netherlands
Adequate
introduction of therapeutic neovascularization in patients with peripheral
arterial disease requires functional monitoring of vascular responses. The
potential of the medium-sized contrast agent Gadomer for detecting (patho-)
physiological perfusion differences with DCE-MRI was tested in a rabbit hind
limb ischemia model. The lower extravasation rate of Gadomer requires a
pharmacokinetic model that includes the blood plasma fraction vp rather than
a model that accounts for reflux. Gadomer proved equally successful as
Gd-DTPA in detecting flow differences between red (soleus) and white
(tibialis) muscle, and between ischemic and normal soleus muscle tissue,
while facilitating better image quality.
Keywords